ProPhase Labs Inc (NAS:PRPH)
$ 4.98 -0.16 (-3.11%) Market Cap: 95.01 Mil Enterprise Value: 117.12 Mil PE Ratio: 0 PB Ratio: 2.00 GF Score: 55/100

Q2 2022 Prophase Labs Inc Earnings Call Transcript

Aug 11, 2022 / 03:00PM GMT
Release Date Price: $11.5 (+7.58%)
Operator

Good morning, and welcome to the ProPhase Labs second-quarter 2022 financial results and corporate update. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Ted Karkus, CEO and Chairman of the Board of ProPhase Labs. Please go ahead.

Ted Karkus
ProPhase Labs, Inc. - Chairman & CEO

Thanks so much. Thank you, all, for joining me today. Before start, unfortunately, I have to read the forward-looking statement. I'll read it quickly. I think you all know what it is.

Before we begin today's call, I want to advise everyone that today's conference call will contain forward-looking statements, including statements relating to our plans, expectations, future performance, and future events, including statements regarding projected financial results of the third quarter of 2022, our expectations regarding the COVID-19 pandemic, future waves of the pandemic and continued demand for diagnostic testing, source of funding, the HRSA funding, our plans to grow our diagnostic business and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot